drugset / Trial / NCT01490190

Study of the Use of a Contraceptive Vaginal Ring (NuvaRing) in Normal Daily Practice in Indian Women (P07733)

NCT01490190

Phase 4 Completed 252 enrolled Organon and Co
NaSingle-groupOpen-labelPrevention

Summary

This study will collect information on cycle control, acceptability and tolerability of the vaginal contraceptive ring (NuvaRing) as used in normal daily practice by Indian women.

Timeline

Start
2011-12-26
Primary completion
2012-12-05
Completion
2012-12-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Etonogestrel Unknown 0.12 mg Other
Subject ethinyl estradiol Small molecule 0.015 mg Other

Indications

No indication recorded.